Patrick Burnett, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 15,000 shares at $26.52 ($395K) on 2026-08-11, disclosed to the SEC on 2026-08-13.
Seasonal sale ($395k) by See Remarks — this insider has traded ARQT in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.52 | 8,300 | $220K | 55.7% |
| 2 | $26.08 | 6,700 | $175K | 44.3% |
| Total | $26.33 avg | 15,000 | $395K | 100% |
| Filing → |
| ARQT | SELL | 2026-05-13 | $5K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $16K | — | Filing → |
| ARQT | SELL | 2026-03-03 | $317K | — | Filing → |